The treatment of obesity in the United States has entered a new era after regulators approved the first-ever oral medication for chronic Read More
Tags :GLP-1 drugs
Eli Lilly & Co. delivered another blowout quarter, lifting its full-year forecast after earnings and revenue soared past Wall Street’s expectations — Read More